期刊文献+

奥沙利铂联合雷替曲塞治疗老年晚期结直肠癌患者的疗效 被引量:2

Efficacy of Oxaliplatin Combined with Raltitrexed in the Treatment of Elderly Patients with Advanced Colorectal Cancer
下载PDF
导出
摘要 目的分析奥沙利铂联合雷替曲塞在老年晚期结直肠癌患者中的治疗效果。方法 60例老年结直肠癌患者均为2016年1月至2018年6月朝阳市中心医院所收治,随机将其分为观察组(n=30,奥沙利铂联合雷替曲塞治疗)和对照组(n=30,常规治疗)。比较两组患者的治疗效果及不良反应发生情况。结果观察组患者的治疗总有效率为86.67%,对照组为63.33%,差异有统计学意义(P <0.05);观察组患者的不良反应总发生率低于对照组,差异有统计学意义(P <0.05)。结论针对老年晚期结直肠癌患者,采用奥沙利铂联合雷替曲塞进行治疗具有满意的效果,不仅可抑制肿瘤病情的发展,还能减少传统治疗方法导致的不良反应,这对于延长患者的生存时间、改善预后具有重要意义。 Objective To analyze the therapeutic effect of oxaliplatin combined with raltitrexed in elderly patients with advanced colorectal cancer,and to find an effective method for the intervention of advanced colorectal cancer.Methods All 60 elderly patients with colorectal cancer were admitted to Chaoyang Central Hospital from January 2016 to June 2018.They were randomly divided into observation group(n=30,oxaliplatin combined with raltitrexed treatment)and control group Group(n=30,conventional treatment).The treatment effects and adverse reactions of the two groups of patients were compared.Results The effective rate of the observation group was 86.67%,which was higher than that of the control group(63.33%),the difference between the groups was significant(P<0.05).The number of adverse reactions in the observation group was lower than that in the control group,the difference between the groups was significant(P<0.05).Conclusion In the clinical treatment of advanced colorectal cancer in the elderly,the treatment with oxaliplatin combined with raltitrexed has a satisfactory effect,which can not only inhibit the development of cancer,but also reduce the adverse reactions in traditional treatment methods.Prolonging the survival time of patients and improving the prognosis are of great significance.
作者 刘艳杰 LIU Yanjie(Chaoyang Central Hospital,Chaoyang 122000,China)
机构地区 朝阳市中心医院
出处 《中国医药指南》 2020年第24期105-106,共2页 Guide of China Medicine
关键词 结直肠癌 老年 奥沙利铂 雷替曲塞 不良反应 Advanced colorectal cancer Elderly Oxaliplatin Raltitrexed Adverse reactions
  • 相关文献

参考文献11

二级参考文献59

  • 1Stravopodis DJ, Karkoulis PK, Konstantakou EQ, et al. Thymidylatesynthase inhibition induces P53-dependent and P-53 -independent ap-optotic response in human urinary bladder cancer ceils[ J]. J CancerRes Clin Oncol,2011,137(2) :359-374.
  • 2Hong YS,Lim HY,Lee J,et al. S-l plus oxaliplatin versus capecitabineplus oxaliplatin for,first-line treatment of patients with metastatic colo-rectal cancer: a randomised,non-inferiority phase 3 trial [ J] . LancetOncol,2012,13(11) :1125-1132.
  • 3Chibber S, Farhan M f Hassan I,et al. White light-mediated Cu( II)-5 FU interaction augments the chemotherapeutic potential of 5 -FU : anin vitro study[ J]. Tumor Biol,2011,32(5) :881-892.
  • 4Sandler A,Graham C. An openlabel multicenter three-stage phase Dstudy of s-l in combination with cisplatin as first-line therapy for pa-tients with advanced non-small cell lung cancer[ J]. Thorac Oncol,2011,6(8):1400-1406.
  • 5Toda Y, Machida N, Boku N. The role of oral fluoropyrimidines incolorectal cancer treatment-a review [ J ]. Gan To Kaqaku Ryoho,2010,37(7):1198-202.
  • 6Silverstein RA,Visa N. The incorporation of 5-Fluorouracil into RNAaffects the ribonucleolytic activity of the exosome subunit Rrp6 [ J].Mol CancerRes,2011,9:332-340.
  • 7黄国军.替吉奥联合奥沙利铂治疗晚期结直肠癌的临床研究[J].医学信息,2013,26(28) :311.
  • 8董苗英,方凤梅,王美娟.肝炎和肝损害患者凯西莱过敏反应的护理[J].护理学报,2008,15(3):84-85. 被引量:8
  • 9李士军,谭庆丰,陈洪流,李树红.血清肿瘤标志物CEA、CA19-9对结直肠癌的诊断价值[J].肿瘤基础与临床,2010,23(4):298-300. 被引量:10
  • 10王秋梅,黄旭霞,陈双珍.替吉奥联合亚叶酸钙及奥沙利铂治疗晚期结直肠癌病人的观察与护理[J].全科护理,2012,10(22):2050-2051. 被引量:3

共引文献98

同被引文献27

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部